Sorrento Therapeutics, Inc.

CIK 850261 · last filed 2023-10-05

Sorrento Therapeutics, Inc. is a corporate insider who has filed 8 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for CELUW, was dated Oct 5, 2023. Current disclosed insider exposure totals $354.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$354.9K

Companies

2

Total Filings

8

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CELUW	10%+ Owner	5,050,427	$0.00	$9.6K	$0	1	2023-10-05
SCLXW	10%+ Owner	1,917,210	$0.18	$345.3K	$0	7	2023-09-25

Recent Filings

8 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-10-05	CELUW	Sell (S)	−15,371,697	$0	EDGAR
2023-09-25	SCLXW	Sell (S)	−60,068,585	$0	EDGAR
2023-01-23	SCLXW	Other (J)	−73,740,795	$0	EDGAR
2022-12-02	SCLXW	Buy (P)	—	$0	EDGAR
2022-11-25	SCLXW	Buy (P)	—	$0	EDGAR
2022-11-23	SCLXW	Buy (P)	—	$0	EDGAR
2022-11-22	SCLXW	Buy (P)	—	$0	EDGAR
2022-11-15	SCLXW	Other (J)	—	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.